Fulgent GeneticsvsThermo Fisher Scientific

FLGT and TMO stock compared: price, dividend, valuation and results, from SEC filings.

FLGT

Fulgent Genetics, Inc.

$24.07

Value $673M

-2.37%
FLGT's page

TMO

Thermo Fisher Scientific Inc

$691.33

Value $257B

-1.27%
TMO's page

Fulgent Genetics (FLGT) has a market value of $673M and Thermo Fisher Scientific (TMO) $257B. Over the last year, with dividends, FLGT moved -17.3% and TMO +19.9%. Dividend yield: FLGT none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    FLGT$673M

    TMO$257B

    TMO is 382 times FLGT

  • Revenue, 12 months

    FLGT$330M

    TMO$47.4B

    TMO is 143 times FLGT

  • Net income, 12 months

    FLGT-$91M

    TMO$7.1B

  • Operating margin

    FLGT-39.2%

    TMO17.9%

    57.1 points apart

  • ROIC

    FLGT-9.7%

    TMO8.2%

    17.9 points apart

  • P/E

    FLGT–

    TMO36.3

  • Dividend yield

    FLGT0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    FLGT-74.2%

    TMO+10.9%

    85.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

FLGT-74.2%

TMO+10.9%

5010020222023202420252026
Returns by period
PeriodFLGTWith dividendsTMOWith dividends
1 year since November 14, 2025-17.3%Price -17.3%+19.9%Price +19.5%
3 years since November 16, 2023-12.9%-4.5% a yearPrice -12.9%+47.7%+13.9% a yearPrice +46.3%
5 years since November 15, 2021-74.2%-23.8% a yearPrice -74.2%+10.9%+2.1% a yearPrice +9.3%
10 years since November 16, 2016+177.4%+10.7% a yearPrice +177.4%+375.7%+16.9% a yearPrice +362.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

FLGTFulgent GeneticsTMOThermo Fisher Scientific

Valuation

FLGTTMO
Valuation
Price$24.07$691.33
Market value$673M$257B
Enterprise value (EV)$382M$292B
P/E–36.3
P/E, 5-year median–32.7
P/B0.74.7
EV/EBIT–34.5
Free cash flow yield–3.0%

Results and growth

FLGTTMO
Results and growth
Revenue, 12 months$330M$47.4B
Net income, 12 months-$91M$7.1B
Free cash flow, 12 months-$1.4M$7.6B
Earnings per share, 12 months-$2.91$18.96
Revenue growth, year on year13.8%3.9%
Revenue growth a year, past-5.2%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

FLGTTMO
Margins and returns on capital
Gross margin33.8%–
Operating margin-39.2%17.9%
Net margin-27.5%14.9%
ROIC-9.7%8.2%
ROE-8.6%13.4%

Balance sheet

FLGTTMO
Balance sheet
Cash$293M$6.1B
Total debt$10M$41.4B
Net debt / EBITDA–3.7
Interest cover-1,307.9×5.5×

Dividends and buybacks

FLGTTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield1.6%1.2%
Shareholder yield1.6%1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: FLGT or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Fulgent Genetics or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($257B) is about 381.8 times Fulgent Genetics ($673M), at today's prices.

How did FLGT and TMO stock do over the last 10 years?

Since November 16, 2016, FLGT's price moved +177.4% and TMO's +362.5%. With dividends: FLGT +177.4% (+10.7% a year), TMO +375.7% (+16.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, FLGT or TMO?

The dividend yield at today's price is none for Fulgent Genetics and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

Which has the higher profit margins, Fulgent Genetics or Thermo Fisher Scientific?

Over the last twelve months, the net margin was -27.5% for Fulgent Genetics and 14.9% for Thermo Fisher Scientific, and the operating margin -39.2% and 17.9%. Revenue was $330M and $47.4B.

Which is the better investment, Fulgent Genetics or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.